The story of Sildenafil presents a challenging picture for investors. While the initial launch generated substantial profits, the expiration of its patent opened the door to cheaper versions, dramatically diminishing https://emilyywaw221200.bloggactivo.com/40848136/sildenafil-and-the-pharmaceutical-industry-a-volatile-bet